Trump Medicare Drug Pricing Model May Apply to Only Four Companies After Exemptions

https://www.medscape.com/s/viewarticle/trump-medicare-drug-pricing-model-may-apply-only-four-2026a10010tb?src= NEW YORK, Oct 1 (Reuters) - A Trump administration rule to cut hospital drug prices for Medicare patients ⁠may apply to as few as four drugmakers after exempting companies that signed separate "most favored ⁠nation" pricing agreements with the administration, according to the finalized rule. According to ⁠the rule published on Wednesday ‌evening, Medicare's regulator plans to waive the requirement manufacturers that have signed separate deals with the White House participate in the price-setting model, called GLOBE.